Skip to content

clinical trial of a software for automatically analyzing and screening cervical cells

clinical trial of a software for automatically analyzing and screening cervical cells

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031487
Enrollment
Unknown
Registered
2020-04-02
Start date
2020-05-06
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Gold Standard:The diagnoses made by pathology doctors after specimens are observed under microscope
Index test:caculate&#32
the&#32
rate&#32
for&#32
with&#32

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The slide of cervical liquid-based cytology with Pap stain was made in the last year; 2. The slide was made by sedimentation and stained well ,clean on the surface; 3. The picture scanned from the slide demonstrates all the information precisely,namely,with accurate color,high definition and was well-bedded, the cells are not left out after the scanning; 4. The format of the picture is TIF/KFB/TMAP; 5. The resolution ratio is 40x.

Exclusion criteria

Exclusion criteria: 1. The slide is broken,or the picture is incomplete; 2. The squamous cells are less than 5000 in each slide; 3. The specimen cannot be traced back to its provider; 4. More than 75% of the epithelial cells cannot be seen clearly due to blood cells,thick inflammatory exudation,bad setting,dry air, man-made contamination.

Design outcomes

Primary

MeasureTime frame
agreement rate;SPE, SEN, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactLi Liang

Southern Medical University

lli@fimmu.com+86 20—88529757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026